Patents Assigned to ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
  • Patent number: 11618766
    Abstract: Disclosed in the present disclosure is a method for preparing 16alpha-hydroxyprednisolone, belonging to the technical field of medicine preparation and processing. In the method, 21-hydroxypregna-1,4,9(11),16-tetraene-3,20-dione-21-acetate is used as a starting material, and subjected to oxidation, bromo-hydroxylation, debromination and alcoholysis, so as to prepare 16alpha-hydroxyprednisolone. The method for preparing 16alpha-hydroxylprednisolone of the present disclosure can effectively control the generation of impurities in the reaction process by improving the disadvantages of traditional processes, and has a mild reaction process and a high overall conversion rate; and the method of the present disclosure has low requirements for a reaction device and low operation costs, is easy to operate, is suitable for industrial production, and has a good market prospect.
    Type: Grant
    Filed: September 20, 2022
    Date of Patent: April 4, 2023
    Assignee: ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
    Inventors: Zhenping Shao, Rong Wang, Kegang Chen, Bingqian Wang, Youfu Wang
  • Publication number: 20230028248
    Abstract: Disclosed in the present disclosure is a method for preparing 16alpha-hydroxyprednisolone, belonging to the technical field of medicine preparation and processing. In the method, 21-hydroxypregna-1,4,9(11),16-tetraene-3,20-dione-21-acetate is used as a starting material, and subjected to oxidation, bromo-hydroxylation, debromination and alcoholysis, so as to prepare 16alpha-hydroxyprednisolone. The method for preparing 16alpha-hydroxylprednisolone of the present disclosure can effectively control the generation of impurities in the reaction process by improving the disadvantages of traditional processes, and has a mild reaction process and a high overall conversion rate; and the method of the present disclosure has low requirements for a reaction device and low operation costs, is easy to operate, is suitable for industrial production, and has a good market prospect.
    Type: Application
    Filed: September 20, 2022
    Publication date: January 26, 2023
    Applicant: ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
    Inventors: Zhenping SHAO, Rong WANG, Kegang CHEN, Bingqian WANG, Youfu WANG